
Çмú´ëȸ VOD
´ëÇÑ´ëÀåÇ×¹®ÇÐȸ Á¦58Â÷ Çмú´ëȸ
Korean Society of Coloproctology 58th Annual MeetingÀÏ ½Ã: 2025³â 4¿ù 4ÀÏ~ 4¿ù 6ÀÏ, Àå ¼Ò: ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ
2025³â 4¿ù 4ÀÏ(±Ý)
[Abstract] Basic & Translational Research 1
08:30-08:40 | Optimization of chitosan/hyaluronic acid-based hybrid patchs for anti-adhesive and prevention of anastomosis leakage | °¼öÁø | °æºÏ´ëÇб³º´¿ø | ![]() |
08:40-08:50 | Anticancer effect of PLK1 degrading PROTAC in colorectal cancer | °µ¿Çö | ¼øÃµÇâ´ëÇб³ õ¾Èº´¿ø | |
08:50-09:00 | Rearrangement of actomyosin cytoskeleton modulated with 3D-spheroids via RhoA/ROCK in internal anal sphincter-targeting model; preliminary results | ¼ÕÀÏÅ | ÇѸ²´ëÇб³ ¼º½Éº´¿ø | ![]() |
09:00-09:10 | Impact of contrast phases on area and radiodensity measurements of skeletal muscle and adipose tissue | °Á¤Çö | ¿¬¼¼ÀÇ´ë °³²¼¼ºê¶õ½ºº´¿ø | |
09:10-09:20 | Appendicitis-targeted generative enhanced image synthesis and three-dimensional deep learning-based diagnosis in non-contrast CT | ±è¹Î¼º | ÇѸ²´ëÇб³ ¼º½Éº´¿ø | |
09:20-09:30 | Metagenomic profiling of the gut microbiome for predicting complete response to total neoadjuvant treatment in rectal cancer | ÇãÁö¿ø | Ãæ³²´ëÇб³ »ý¸íÁ¤º¸À¶ÇÕÇаú |
[Abstract] IBD & Benign 1
08:30-08:40 | Spatial transcriptomic analysis for genetic profiling of colitis-associated colorectal cancer in ulcerative colitis | ¹ÚÀºÁ¤ | ¿ï»ê´ëÇб³ Àǰú´ëÇÐ ¼¿ï¾Æ»êº´¿ø | |
08:40-08:50 | Comparing surgical outcomes between Crohn’s disease and Gastrointestinal Behcet’s disease: a single-center retrospective cohort study | ½Åµ¿Çö | ¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø | ![]() |
08:50-09:00 | Impact of aged care facility residence on 30-day mortality after emergency abdominal surgery for acute abdomen in the elderly | ±èÁÖ¿¬ | ±¹¹Î°Ç°º¸Çè°ø´Ü Àϻ꺴¿ø | ![]() |
09:00-09:10 | Analysis of extraintestinal manifestations in Korean patients with inflammatory bowel disease; A nationwide population-based study | ¹Ú¼º½Ç | ÇѾç´ëÇб³º´¿ø | ![]() |
09:10-09:20 | ¿°Áõ¼º ÀåÁúȯÀÇ Ä¡·á °æÇâ º¯È: ´ÜÀϱâ°ü ÈÄÇâÀû ºÐ¼® | ¹è¿¹ÁØ | °í·ÁÀÇ´ë | |
09:20-09:30 | Comparison of hernia surgery outcomes in patients with and without prior prostatetectomy or cystectomy: A propensity score-matched analysis | À¯È¿¼± | °í·Á´ëÇб³ ¾È¾Ïº´¿ø | ![]() |
[Abstract] Neoplasia 1
08:30-08:40 | Long-term outcomes according to the management of responsive lateral nodes after CCRT followed by rectal cancer surgery (RESPONDER): A multicenter retrospective cohort study using IPTW | ¿ÀÈï±Ç | ºÐ´ç¼¿ï´ëÇб³º´¿ø | |
08:40-08:50 | Albumin-myosteatosis gauge, a novel predictor of postoperative complication in colorectal cancer surgery with nomogram | Á¶ÇýÁ¤ | ¿¬¼¼´ëÇб³ Àǰú´ëÇÐ °³²¼¼ºê¶õ½ºº´¿ø | |
08:50-09:00 | Serial ctDNA analysis in stage IV colorectal cancer | ¹®Áö¿¬ | °¡Å縯ÀÇ´ë ¼ººó¼¾Æ®º´¿ø | ![]() |
09:00-09:10 | Size matters: Establishing a cut-off for rectal neuroendocrine neoplasm to predict recurrence and standardize surveillance guidelines | ±è¼¼Á¤ | ¼º±Õ°ü´ëÇб³ Àǰú´ëÇÐ | |
09:10-09:20 | Comparative analysis of clinical characteristics between recurrence and non-recurrence patients after 5 years in colorectal cancer | ¹ÚÁ¦¼º | ¼¿ï´ëÇб³º´¿ø | ![]() |
09:20-09:30 | Neoadjuvant chemotherapy with four cycles of FOLFOX for locally advanced colon cancer: A multicenter prospective randomized controlled trial | ¹Ú¼ö¿¬ | °æºÏ´ëÇб³ Àǰú´ëÇÐ |
[Next Generation] Painful Memories & Mistakes to Become a Great Surgeon
10:00-10:20 | UFO (Unidentified foreign object) | ±èâ¿ì | ¾ÆÁÖÀÇ´ë | |
10:20-10:40 | Panic situations in operating room | À¯½Â¹ü | ¼¿ïÀÇ´ë | |
10:40-11:00 | Sleepless in anastomosis | ¹ÚÁؼ® | °æºÏÀÇ´ë | |
11:00-11:20 | The struggles and growth that come with every step | °èºÀÇö | °¡Å縯ÀÇ´ë |
[Hernia] Optimal Treatment for Difficult Situations
10:00-10:20 | Recurred inguinal hernia | ÀÌö½Â | ÇѼֺ´¿ø | ![]() |
10:20-10:40 | Incarcerated or strangulated inguinal hernia | ±èÁöÈÆ | °¡Å縯ÀÇ´ë | ![]() |
10:40-11:00 | Obturator/Femoral hernia | ±èÁ¾Å | ÁøÁÖÁ¦ÀϺ´¿ø | ![]() |
11:00-11:20 | Traumatic hernia | ±è¿µ¹Î | °¡ÃµÀÇ´ë |
[Chemotherapy] Let's Dive into Chemotherapy to Be a Master of Oncology
10:00-10:15 | Real practice and essentials for outpatient and inpatient chemotherapy | ¼º³«¼Û | °Ç¾çÀÇ´ë | ![]() |
10:15-10:30 | All about chemotherapy induced adverse effect and its management to complete chemotherapy | ±èÁ¾¿Ï | ÇѸ²ÀÇ´ë | |
10:30-10:45 | Evidence for adjuvant chemotherapy in rectal cancer after neoadjuvant chemotherapy | °¼ºÀÏ | ¿µ³²ÀÇ´ë | ![]() |
10:45-11:00 | Current evidence and role of ct-DNA for chemotherapy in colorectal cancer | °µ¿Çö | ¼øÃµÇâÀÇ´ë | |
11:00-11:15 | Optimal therapeutic strategies for systemic chemotherapy in metastatic colorectal cancer | À̰æÇÏ | Ãæ³²ÀÇ´ë | ![]() |
Luncheon Symposium (Sponsored by ONO Pharma)
11:30-12:00 | A new standard treatment (BRAFTOVI¢ç) for BRAF V600E mutant mCRC | ¹è±â¹ü | ÀÎÁ¦ÀÇ´ë |
[Áø·á±Ç°í¾ÈÀ§¿øÈ¸] Rectal Cancer Guideline v2.0: What's New
13:00-13:20 | The role of radiotherapy in the treatment of upper rectal cancer | À̱æ¿ë | °¡Å縯ÀÇ´ë | |
13:20-13:40 | Immunotherapy as a neoadjuvant treatment for locally advanced rectal cancer | ±èÁø¿ø | ¼¿ïÀÇ´ë Á¾¾ç³»°ú | ![]() |
13:40-14:00 | Is it okay to watch-and-wait? | Áö¿õ¹è | °í·ÁÀÇ´ë | ![]() |
14:00-14:20 | Reviewing the oncologic outcomes of Transanal TME | ³ë°æÅ | ÀÌÈÀÇ´ë | ![]() |
[Benign Colorectal Disease] All about Constipation & Ischemic Colitis
13:00-13:20 | Pseuobstruction and slow transit constipation: causes and diagnosis/medical treatment | ±èÂù¿í | ¿ï»êÀÇ´ë | |
13:20-13:40 | Pseuobstruction and slow transit constipation: surgical options and the best timing | ÇÏ±â¿ø | ÀüºÏÀÇ´ë | ![]() |
13:40-14:00 | Management of ischemic colitis: medical treatment and long-term outcomes | ¹®Èñ¼® | Ãæ³²ÀÇ´ë ¼Òȱ⳻°ú | ![]() |
14:00-14:20 | Surgical management for ischemic colitis: various options (indication, anastomosis) | ¾ç¼º¼ö | ¿ï»êÀÇ´ë | ![]() |
[ÀÇ·áÁúÇâ»ó µ¥ÀÌÅÍÀ§¿øÈ¸] K-QIPS in Colorectal Surgery: Reflecting on the Past, Advancing Toward the Future
13:00-13:20 | K-QIPS CRS: Review the past 3 years and plan the next 3 years | ¹ÚÀ±¿µ | °æÈñÀÇ´ë | |
13:20-13:40 | Reviewing surgical risk calculation tools from global surgical quality improvement projects and planning a suitable approach for us | ¼Û½ÂÈ£ | °æºÏÀÇ´ë | ![]() |
13:40-14:00 | What are research outcomes of K-QIPS CRS? | Á¤Áø¿Á | °í·ÁÀÇ´ë | |
14:00-14:20 | Data Integrity: The current data audit status and suggestion for improvement | À±¼ø¼® | °í·ÁÀÇ´ë | ![]() |
Break (Video 1 - Surgeon's Square)
14:30-14:40 | Optimal strategies to minimize the risk of anastomotic leakage: Prerequisites for safe anastomosis | ±èÇýÁø | °æºÏ´ëÇб³ Àǰú´ëÇÐ | |
14:40-14:50 | Comparison of three different incision site approaches for Single-Port (SP) DaVinci¢ç right hemicolectomy | Á¶ÇýÁ¤ | ¿¬¼¼´ëÇб³ Àǰú´ëÇÐ °³²¼¼ºê¶õ½ºº´¿ø | |
14:50-15:00 | Advantages of Da Vinci SP robotic surgery for adhesiolysis and total mesorectal excision in obese rectal cancer patient | ±èÈ£½Â | ÀÌÈÀÇ´ë |
[¿¬±¸À§¿øÈ¸] ´Ù±â°ü ¿¬±¸ & Á¤Ã¥ ¿¬±¸ °ø¸ð
15:00-15:20 | ´Ù±â°ü µ¥ÀÌÅ͸¦ ÅëÇÑ Á÷Àå ½Å°æ³»ºÐºñ Á¾¾çÀÇ Ä¡·á¹æ¹ý¿¡ µû¸¥ ¿¹ÈÄ ºÐ¼® | ¹Ú¼º½Ç | ÇѾçÀÇ´ë | ![]() |
15:20-15:40 | Àü¹æÀýÁ¦¼ú ȤÀº ÀúÀ§Àü¹æÀýÁ¦¼ú ÈÄ º¹¸·¿Ü ÅͳθµÀ» ÅëÇÑ ¹è¾×°ü °íÁ¤¹ýÀÇ È¿¿ë¼º°ú ¾ÈÀü¼º¿¡ ´ëÇÑ ´Ù±â°ü ¹«ÀÛÀ§ ºñ±³ ¿¬±¸ | °¼ºÀÏ | ¿µ³²ÀÇ´ë | ![]() |
15:40-16:00 | °¨½Ã&´ë±â (Watch & Wait, W&W) Àü·« µ¥ÀÌÅͺ£À̽º ±¸Ãà »ç¾÷ | ¹ÚÀ±¿µ | °æÈñÀÇ´ë | |
16:00-16:20 | º´¸®ÇÐÀû ÀúÀ§Ç豺 Á÷Àå¾ÏȯÀÚ¿¡¼ º¸Á¶Ç×¾ÏÈÇпä¹ýÀÇ Çʿ伺¿©ºÎ ¹× À§ÇèÀÎÀÚ ºÐ¼®: ´Ù±â°ü, ÈÄÇâÀû ¿¬±¸ |
±èÀΰæ | °¡Å縯ÀÇ´ë | ![]() |
[Future Medicine] Cancer Biology
15:00-15:20 | Colon cancer organoid model for therapeutic application | ¹Ú¼Ò¿¬ | ÀÌÈ¿©´ë ¾àÇдëÇÐ | ![]() |
15:20-15:40 | Control of microenvironment for colon cancer treatment | Á¶¿ë¹ü | ¼º±Õ°üÀÇ´ë | |
15:40-16:00 | Organs on a chips: design and engineering | ¾È¼ÛÀÌ | Ä«À̽ºÆ® ±â°è°øÇаú | |
16:00-16:20 | Patient-derived xenograft models for breast cancer research | ¹®Çü°ï | ¼¿ïÀÇ´ë À¯¹æ³»ºÐºñ¿Ü°ú | ![]() |
[ÆíÁýÀ§¿øÈ¸] How to Prepare a Good Manuscript
15:00-15:20 | How to initiate paper writing | °»óÈñ | °í·ÁÀÇ´ë | |
15:20-15:40 | How to summarize as attractive table and figure | ¹ÚÀºÁ¤ | ¿ï»êÀÇ´ë | |
15:40-16:10 | Tips for making figures, graphs, and graphical/video abstracts | À嵿¼ö | ¿¬¼¼ÀÇ´ë, ÀÎÆ÷±×·¡ÇÇ´ëÇ¥ | ![]() |
16:10-16:30 | How to pass the review process easily | À̼ö¿µ | Àü³²ÀÇ´ë | ![]() |
[Abstract] Basic & Translational Research 2
17:00-17:10 | Optimal indocyanine green dosage for repetitive angiography for laparoscopic colorectal surgery | ¼Õ°æ¸ð | ¾ç»êºÎ»ê´ëÇб³º´¿ø | ![]() |
17:10-17:20 | Role of tumor microenvironment in the development of cancer cachexia | ±èÈ£½Â | ÀÌÈÀÇ´ë | ![]() |
17:20-17:30 | Biomarkers for predicting therapeutic response to preoperative chemoradiotherapy in rectal cancer | ÀÌÃæ¿± | ¿ï»ê´ëÇб³ Àǰú´ëÇÐ ¼¿ï¾Æ»êº´¿ø | |
17:30-17:40 | Mechanistic insights into radiation resistance in colorectal cancer: Gene exploration study | À̼öÇö | ¼øÃµÇâÀÇ´ë õ¾Èº´¿ø | |
17:40-17:50 | Identification of arginine (di)methylated human leukocyte antigen class I peptides in colon cancer tissues from patients | ÀÓ¿ëö | ¼º±Õ°ü´ëÇб³ Àǰú´ëÇÐ | ![]() |
17:50-18:00 | Early postoperative fever - when is it a reason to delay discharge after colorectal cancer surgery? | ¹ÚÀçÇö | ¼¿ï´ëÇб³º´¿ø | ![]() |
[Abstract] Neoplasia 2
17:00-17:10 | Two-week course versus conventionally fractionated preoperative chemoradiotherapy in locally advanced rectal cancer (TwoArc trial): A phase III multicenter randomized clinical trial | °èºÀÇö | °¡Å縯ÀÇ´ë ¼ººó¼¾Æ®º´¿ø | |
17:10-17:20 | Implications of CME as a predictive factor for peritoneal recurrence of cT3-4 right-sided colon cancer: A multicenter retrospective study | ¼Û½ÂÈ£ | Ä¥°î°æºÏ´ëº´¿ø | ![]() |
17:20-17:30 | The clinical utility of blood-based multi-locus circulating tumor DNA methylation assay for colorectal cancer diagnosis: Prospective case-control study, interim results | ÀÌÇÏ¿µ | °µ¿°æÈñ´ëº´¿ø | ![]() |
17:30-17:40 | Pilot study of implementing prehabilitation program to rectal cancer patients undergoing preoperative concurrent chemoradiation therapy | À¯´Ï³ª | °¡Å縯ÀÇ´ë ¼ººó¼¾Æ®º´¿ø | ![]() |
17:40-17:50 | Nomogram for prediction of lymph node metastasis after neoadjuvant chemoradiotherapy in ypT0-2 rectal cancer | ¹ÚÇü¹Î | ȼøÀü³²´ëÇб³º´¿ø | ![]() |
17:50-18:00 | Endoscopic treatment for rectal neuroendocrine tumors: Comparison among EMR, EMR-P, and ESD | ÀÌÀºÁ¤ | À寰À§Æ°º´¿ø | ![]() |
[Abstract] Neoplasia 3
17:00-17:10 | Impact of inferior mesenteric artery ligation level on anastomotic leakage in low anterior resection: A multicenter RCT | ±èâÇö | Àü³²´ëÇб³ Àǰú´ëÇÐ | ![]() |
17:10-17:20 | Prognostic factors and oncologic benefits of adjuvant chemotherapy in pT3N0 rectal cancer after upfront surgery | °°æ¹Î | ºÐ´ç¼¿ï´ëÇб³º´¿ø | ![]() |
17:20-17:30 | Watch-and-wait policy to defer defunctioning stoma after low anterior resection: Preliminary results from the safe anastomosis project | ±èÇýÁø | °æºÏ´ëÇб³ Àǰú´ëÇÐ | |
17:30-17:40 | Comparison of long-term oncological outcomes between robotic and laparoscopic total mesorectal excision for rectal cancer: A propensity score matching analysis | ¹è¼º¿í | °è¸íÀǴ뵿»êÀÇ·á¿ø | ![]() |
17:40-17:50 | Optimal age cut-off for oxaliplatin-based versus non-oxaliplatin adjuvant chemotherapy in stage II/III colorectal cancer: A Korean population-based study | ºÀÁØ¿ì | °í·Á´ëÇб³ ±¸·Îº´¿ø | ![]() |
17:50-18:00 | Risk factors for LN metastasis in T1 colorectal cancer : A retrospective, single-center, comparative study | ¹ÚÁøÇü | °¡Å縯ÀÇ´ë ÀºÆò¼º¸ðº´¿ø |